SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-154340
Filing Date
2020-05-28
Accepted
2020-05-28 16:47:10
Documents
17
Period of Report
2020-05-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d935570d8k.htm   iXBRL 8-K 38754
2 EX-1.1 d935570dex11.htm EX-1.1 188511
3 EX-5.1 d935570dex51.htm EX-5.1 8332
4 EX-99.1 d935570dex991.htm EX-99.1 7282
5 EX-99.2 d935570dex992.htm EX-99.2 7512
9 GRAPHIC g935570img1.jpg GRAPHIC 8399
  Complete submission text file 0001193125-20-154340.txt   445828

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arna-20200527.xsd EX-101.SCH 3076
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20200527_lab.xml EX-101.LAB 17374
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20200527_pre.xml EX-101.PRE 10957
14 EXTRACTED XBRL INSTANCE DOCUMENT d935570d8k_htm.xml XML 3290
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 20921824
SIC: 2834 Pharmaceutical Preparations